Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use of Buventol Easyhaler and Bufomix Easyhaler as Relievers in Methacholine Challenge Testing
2021-001573-22Phase 4Completed
- Sponsor
- Orion Corporation
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Buventol Easyhaler and budesonide + formoterol in asthma and bronchoconstriction (3 arms), sponsored by Orion Corporation. Primary endpoint: Mean change in FEV1 after dosing. Started Jun 2021; status: completed.
02
Drugs
Buventol Easyhalerbudesonide + formoterol
03
Conditions
asthmabronchoconstriction
Beyond the preview
Go deeper on 2021-001573-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001573-22.